Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 803 participants.

Also called NCT01651780

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 803 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01651780
  • EudraCT 2012-000632-26
Other papers using this trial's data
  • Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial Journal of the American College of Cardiology, 2015-12-29 DOI, PubMed 26477635
  • Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study Journal of the American College of Cardiology, 2016-08-09 DOI, PubMed 27208464

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Canada, France, Germany, Italy, Netherlands, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01651780. Randomized; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2015-06 (actual). Results posted on 2017-02-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
Acronym
BRAVO 2/3
Condition
Severe Aortic Stenosis
Condition
Aortic Valve Replacement
Intervention (Drug)
Bivalirudin
Intervention (Drug)
Unfractionated Heparin
Lead sponsor
The Medicines Company (class: industry)

Record details

Record id
cardio:ct-nct01651780
Content hash
ec6b224078b267e01adff4a2d996db35e61102ef99f46743ef13b60e08b5e7d6